I
RCUS icon

InceptionR’s Arcus Biosciences RCUS Stock Holding History

InceptionR’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268K Buy
+8,677
New +$214K 0.07% 502
2026
Q1 		– Sell
-8,811
Closed -$210K – 853
2025
Q4 		$210K Buy
+8,811
New +$180K 0.06% 533

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

InceptionR's RCUS Position: Q2 2026 in Review

InceptionR opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 8,677 shares worth $268K. The stake represents 0.07% of the portfolio and ranks #502 among its holdings. This is a return to the name: InceptionR previously reported a position in RCUS as recently as Q4 2025.

InceptionR first reported a position in RCUS in Q4 2025 and has held it in 2 quarters since. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • InceptionR held 8,677 shares of Arcus Biosciences worth $268K as of Q2 2026.
  • Arcus Biosciences was a new InceptionR position in Q2 2026.
  • Arcus Biosciences made up 0.07% of InceptionR's portfolio in Q2 2026, its #502 holding.
  • InceptionR first reported a position in Arcus Biosciences in Q4 2025 and has held it in 2 quarters since.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.